Mesenchymal stem cell transplantation for the infarcted heart: A role in minimizing abnormalities in cardiac-specific energy metabolism

Curtis C. Hughey, Virginia L. Johnsen, Lianli Ma, Freyja D. James, Pampee P. Young, David H. Wasserman, Jeffrey N. Rottman, Dustin S. Hittel, Jane Shearer

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Intense interest has been focused on cell-based therapy for the infarcted heart given that stem cells have exhibited the ability to reduce infarct size and mitigate cardiac dysfunction. Despite this, it is unknown whether mesenchymal stem cell (MSC) therapy can prevent metabolic remodeling following a myocardial infarction (MI). This study examines the ability of MSCs to rescue the infarcted heart from perturbed substrate uptake in vivo. C57BL/6 mice underwent chronic ligation of the left anterior descending coronary artery to induce a MI. Echocardiography was performed on conscious mice at baseline as well as 7 and 23 days post-MI. Twenty-eight days following the ligation procedure, hyperinsulinemic euglycemic clamps assessed in vivo insulin sensitivity. Isotopic tracer administration evaluated whole body, peripheral tissue, and cardiac-specific glucose and fatty acid utilization. To gain insight into the mechanisms by which MSCs modulate metabolism, mitochondrial function was assessed by high-resolution respirometry using permeabilized cardiac fibers. Data show that MSC transplantation preserves insulin-stimulated fatty acid uptake in the peri-infarct region (4.25 ± 0.64 vs. 2.57 ± 0.34 vs. 3.89 ± 0.54 μmol·100 g -1·min -1, SHAM vs. MI + PBS vs. MI + MSC; P < 0.05) and prevents increases in glucose uptake in the remote left ventricle (3.11 ± 0.43 vs. 3.81 ± 0.79 vs. 6.36 ± 1.08 μmol·100 g -1·min -1, SHAM vs. MI + PBS vs. MI + MSC; P < 0.05). This was associated with an enhanced efficiency of mitochondrial oxidative phosphorylation with a respiratory control ratio of 3.36 ± 0.18 in MSC-treated cardiac fibers vs. 2.57 ± 0.14 in the infarct-only fibers (P < 0.05). In conclusion, MSC therapy exhibits the potential to rescue the heart from metabolic aberrations following a MI. Restoration of metabolic flexibility is important given the metabolic demands of the heart and the role of energetics in the progression to heart failure.

Original languageEnglish (US)
Pages (from-to)E163-E172
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume302
Issue number2
DOIs
StatePublished - Jan 2012
Externally publishedYes

Keywords

  • Coactivator-1α
  • Hyperinsulinemic euglycemic clamp
  • Mitochondria
  • Peroxisome proliferator-activated receptor-γ
  • Skeletal muscle
  • Substrate uptake

Fingerprint Dive into the research topics of 'Mesenchymal stem cell transplantation for the infarcted heart: A role in minimizing abnormalities in cardiac-specific energy metabolism'. Together they form a unique fingerprint.

Cite this